Skip to main content
. 2022 Apr;23(4):1359–1364. doi: 10.31557/APJCP.2022.23.4.1359

Table 3.

Comparison between the Ttwo Studied Groups According to rs2046211

Breast cancer
(n = 60)
n (%)
Control
(n = 40)
n (%)
(χ2) p OR 95% CI
rs2046211
CC® 54 (90.0) 28 (70.0) 0.011*
CG 6 (10.0) 12 (30.0)
GG 0 (0.0) 0 (0.0) 0.26 0.088 to 0.76
Allele
C® 114 (95.0) 68 (85.0) 0.015* 0.298 0.11 to 0.83
G 6 (5.0) 12 (15.0)

®, Reference Genotype; χ2, Chi square test; p, p value for comparing between the studied groups; *, Statistically significant at p ≤ 0.05; OR, odds ratio; CI, confidence interval